The Peter Attia Drive

#392 - Genetic testing: when it's valuable, how to choose the right test, and what to do with the results

1h 2min

Peter Attia provides a practical framework for thinking clearly about genetic testing, explaining that while it can be genuinely useful for specific, high-impact mutations like BRCA or pharmacogenetics, most commercial tests focusing on common variants (like MTHFR) offer low clinical value. He emphasizes that direct phenotypic measurement (e.g., blood work, imaging) is often more informative than genetic risk prediction, and guides listeners on choosing the right test type and interpreting results with intention.

Summarized by Podsumo

🎧 Listen 🎙️ Ask about this episode

✨ Key Takeaways

1

Genetic testing is best for specific, high-penetrance mutations (e.g., BRCA, Lynch syndrome) where actionability is clear; for most common diseases, directly measuring the phenotype (e.g., cholesterol, blood pressure) is more useful
2

Consumer SNP tests (e.g., 23andMe) only cover common variants and can miss rare, clinically significant mutations—they are not equivalent to clinical-grade gene panels
3

The biggest overhyped tests are functional medicine panels for MTHFR, COMT, and detox genes, which have low effect sizes and often lead to unnecessary supplements
4

Pharmacogenetics is a practical application where genetics can guide medication choice (e.g., Plavix metabolism, allopurinol safety) with clear clinical impact
5

A key principle: 'Test with intention'—know what you are looking for, what you will do with the answer, and be prepared psychologically for the result

💬 Notable Quotes

"Genetic testing can be useful, sometimes very useful, but it is not a perfect blueprint for health, and it does not replace phenotypic data.” — Peter Attia"
"The more of the genome you look at, the more likely you are to find something, but finding something is not the same as finding something useful.” — Peter Attia"
"Test with intention. Know what you're looking for. Know what you'll do when you find it out, and know what you will do if you don't.” — Peter Attia"